A third-generation trifocal platform designed to deliver a smooth, continuous range of high-contrast vision across all distances — in any lighting condition.

Discover the Design

Built on the original FINEVISION® trifocal platform
supported by U.S. clinical data and decades of global experience

Continuous High-Contrast Range of Vision Across All Lighting Conditions

Clinical Evaluation
POD F GF: Binocular Defocus Curve (D), photopic, 6 months1

  • The defocus profile demonstrates a smooth, continuous range of high‑contrast vision, supported by a dual‑add design (+3.50 D and +1.75 D).
  • High rates of 20/25 vision at all distances, including near, with consistent range of vision across pupil sizes.¹

The Perfect Balance of Enhanced Near Vision
and High-Contrast Vision in Dim Lighting

Optimized to See the Fine Details
  • +3.50 D near add for strong near performance
  • ~34% of light allocated to near
  • Enhanced ability to see fine details at 35–40 cm
  • Balanced light distribution across all focal points
  • Maintains distance and intermediate performance1,2

Vision Performance in Mesopic Lighting

Consistent contrast sensitivity & visual performance in mesopics conditions.3

Distinct by Design

ADVANCED DIFFRACTIVE OPTIC

Rounded diffractive peaks with gentle apodization across the anterior surface, creating +1.75 D intermediate and +3.50 D near add powers.

DOUBLE C-LOOP HAPTIC STABILITY

Unique POD double C-loop providing four in-bag contact points and approximately 120° contact angle.

HYDROPHOBIC MATERIAL PLATFORM

Constructed from GFY® hydrophobic acrylic.

Designed for Controlled Delivery

after the video html:

Discover Our Lens

MODEL:

PODF GF

HAPTIC DESIGN:

POD (Double-C-loop) with Ridgetech®
& Posterior 5° Angulated Haptic

SPHERICAL POWER:

+10D to +30D (0.5D steps)

OPTIC:

Biconvex Aspheric Trifocal

MATERIALS & FILTRATION:

GFY Hydrophobic Acrylic4
UV & Selective Blue-Violet Light Filter (~400-450nm)

The Original Trifocal

Launched in Europe in 2010 through the collaboration of Prof. Damien Gatinel, MD, PhD, and the BVI R&D team, the FINEVISION platform introduced a new optical design concept that marked an important milestone in the evolution of trifocal technology. FINEVISION HP brings this proven third-generation hydrophobic trifocal technology to the United States.








    References:
    1. FINEVISION HP DFU, 2025. | 2. Ang R. Long Term Clinical Outcomes of Hydrophilic and Hydrophobic Versions of a Trifocal IOL with the same optical design. Clin Ophthalmol. 2023;17:623-632. | 3. Poyales F, Perez R, Lopez-Brea I, Zhou Y, Rico L, Garz.n N. Comparison of Visual Performance and Patient Satisfaction Outcomes with Two Trifocal IOLs with Similar Optical Design but Different Materials. Clin Ophthalmol. 2020;14:3237-3247. | 4. GFY. is patented since 2010. Patent number: EP1830898. | 5. Values estimated only: surgeons are recommended to personalize their A-constant based on their surgical techniques and equipment, experience with the lens model and postoperative results.
    FINEVISION® is a registered trademark of BVI Medical.
    1901364-01